JP Morgan Chase
CINC

JP Morgan Chase’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

JP Morgan Chase’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-198,946
Closed -$2.44M – 7494
2022
Q4 		$2.44M Buy
198,946
+6,217
+3% +$148K ﹤0.01% 3411
2022
Q3 		$6.33M Sell
192,729
-1,616
-0.8% -$45.7K ﹤0.01% 2521
2022
Q2 		$3.66M Buy
194,345
+188,904
+3,472% +$3.62M ﹤0.01% 3055
2022
Q1 		$95K Buy
+5,441
New +$112K ﹤0.01% 5537

JP Morgan Chase's CINC Position: Q1 2023 in Review

JP Morgan Chase sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 198,946 shares — an estimated $2.44M sold.

JP Morgan Chase first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $6.33M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • JP Morgan Chase reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 198,946 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $2.44M.
  • JP Morgan Chase first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • JP Morgan Chase's CinCor Pharma, Inc. Common Stock position peaked at $6.33M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.